TSE:KPT KP Tissue (KPT) Stock Price, News & Analysis → The AI Bottleneck No One is Talking About (From The Bull Report) (Ad) Free KPT Stock Alerts C$9.03 +0.09 (+1.01%) (As of 03/18/2024 ET) Add Compare Share Share Today's RangeC$8.96▼C$9.0350-Day RangeC$8.24▼C$9.0352-Week RangeC$8.20▼C$10.84Volume22,834 shsAverage Volume19,093 shsMarket CapitalizationC$89.94 millionP/E RatioN/ADividend Yield7.97%Price TargetC$9.88 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider Trades Get KP Tissue alerts: Email Address KP Tissue MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside9.4% UpsideC$9.88 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.39Based on 6 Articles This WeekInsider TradingAcquiring SharesC$1,338 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.23 out of 5 stars 1.2 Analyst's Opinion Consensus RatingKP Tissue has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of C$9.88, KP Tissue has a forecasted upside of 9.4% from its current price of C$9.03.Amount of Analyst CoverageKP Tissue has only been the subject of 2 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for KPT. Previous Next 1.7 Dividend Strength Dividend LeadershipKP Tissue is a leading dividend payer. It pays a dividend yield of 8.38%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthKP Tissue does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for KPT. Previous Next 1.9 News and Social Media Coverage News SentimentKP Tissue has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Defensive companies.News Coverage This WeekMarketBeat has tracked 6 news articles for KP Tissue this week, compared to 1 article on an average week.MarketBeat FollowsOnly 1 people have added KP Tissue to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, KP Tissue insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$1,338.00 in company stock and sold C$0.00 in company stock.Percentage Held by InsidersOnly 0.14% of the stock of KP Tissue is held by insiders.Percentage Held by InstitutionsOnly 13.33% of the stock of KP Tissue is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of KP Tissue is -11.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of KP Tissue is -11.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDue to a projected decrease in earnings for KP Tissue, their PEG ratio cannot be calculated.Price to Book Value per Share RatioKP Tissue has a P/B Ratio of 1.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. About KP Tissue Stock (TSE:KPT)KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under the Cashmere, SpongeTowels, Scotties, Purex, Bonterra, Purex, Metro, White Swan, Embassy, and Chalet brand names, as well as under private labels. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.Read More KPT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KPT Stock News HeadlinesMarch 19, 2024 | americanbankingnews.comKP Tissue (TSE:KPT) Stock Passes Below Two Hundred Day Moving Average of $9.26March 14, 2024 | theglobeandmail.comIt’s 1995, with big gains ahead, not 1999 says prominent U.S. market strategistMarch 19, 2024 | InvestorPlace (Ad)They said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.March 12, 2024 | theglobeandmail.comCEO of KP Tissue continues to add assets, manage risks of pulp pricesMarch 12, 2024 | americanbankingnews.comKP Tissue (TSE:KPT) Price Target Cut to C$9.00 by Analysts at CIBCMarch 11, 2024 | americanbankingnews.comAnalysts Issue Forecasts for KP Tissue Inc.'s Q1 2024 Earnings (TSE:KPT)March 10, 2024 | americanbankingnews.comKP Tissue (TSE:KPT) Price Target Cut to C$9.00March 10, 2024 | americanbankingnews.comKP Tissue (TSE:KPT) PT Lowered to C$9.50March 19, 2024 | Paradigm Press (Ad)8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: March 7, 2024 | msn.comKP Tissue GAAP EPS of C$0.20, revenue of C$482.3M; initiates Q1 outlookMarch 5, 2024 | finance.yahoo.comKRUGER PRODUCTS ANNOUNCES MAJOR INCREASE IN ITS FACIAL TISSUE PRODUCTION CAPACITY WITH AN INVESTMENT OF $14.5 MILLIONFebruary 22, 2024 | morningstar.comKP Tissue Inc KPTFebruary 17, 2024 | investing.comKP Tissue Inc (KPT)February 7, 2024 | finance.yahoo.comKP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Fourth Quarter of 2023January 31, 2024 | ca.finance.yahoo.comKP Tissue Inc. (KPT.TO)November 8, 2023 | finanznachrichten.deKP Tissue Inc.: KP Tissue Releases Third Quarter 2023 Financial ResultsOctober 9, 2023 | finance.yahoo.comKP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Third Quarter of 2023October 7, 2023 | theglobeandmail.comClosing Bell: Kp Tissue Inc flat on Friday (KPT)September 29, 2023 | finance.yahoo.comUnraveling the Dividend Saga of KP Tissue Inc (KPTSF)August 29, 2023 | finance.yahoo.comKP Tissue's (TSE:KPT) Dividend Will Be CA$0.18August 15, 2023 | theglobeandmail.comClosing Bell: Kp Tissue Inc down on Monday (KPT)August 10, 2023 | finance.yahoo.comKP Tissue Releases Second Quarter 2023 Financial ResultsJuly 17, 2023 | msn.comInnovation and Adaptation: KP Tissue Ensures Consistency amidst Decreased PerformanceJuly 10, 2023 | finance.yahoo.comKP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Second Quarter of 2023May 12, 2023 | msn.comKP Tissue (KPTSF) Declares $0.18 DividendMay 11, 2023 | finanznachrichten.deKP Tissue Inc.: KP Tissue Releases First Quarter 2023 Financial ResultsMay 11, 2023 | marketwatch.comREMINDER - KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the First Quarter of 2023See More Headlines Receive KPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KP Tissue and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 1/15 Dividend12/29/2023Dividend Payable1/15/2024Today3/18/2024Ex-Dividend for 4/15 Dividend3/28/2024Dividend Payable4/15/2024Next Earnings (Estimated)5/09/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorConsumer Defensive Industry Household & Personal Products Sub-IndustryN/A Current SymbolTSE:KPT CUSIPN/A CIKN/A Webkptissueinc.com Phone+1-905-8126900FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price TargetC$9.88 High Stock Price TargetC$12.00 Low Stock Price TargetC$9.00 Potential Upside/Downside+9.4%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.79) Trailing P/E RatioN/A Forward P/E Ratio25.78 P/E Growth-0.88Net IncomeC$-7,890,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-10.08% Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.23 Quick Ratio1.23 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueC$7.30 per share Price / Book1.24Miscellaneous Outstanding Shares9,960,000Free FloatN/AMarket CapC$89.94 million OptionableNot Optionable Beta0.35 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Dino J. Bianco (Age 62)Chief Executive Officer Comp: $737.68kMr. Mark HolbrookChief Financial OfficerMr. Michel ManseauSenior VP & GM of Consumer Business Canada - Kruger Products LPMr. Gordon GossSenior VP and GM of Consumer Business USA & Mexico - Kruger Products LPMr. Marc James FitzgeraldCorporate Vice President of Technology & Product Development - Kruger Products LPMike Baldesarra CPACA, Director of Investor RelationsMr. François ParoyanSVP of General Counsel & Corporate Affairs and Corporate SecretaryMr. Rob LatterSenior VP & GM of Away from Home Business - Kruger Products LPMs. Nancy MarcusChief Marketing Officer of Kruger Products LPMs. Susan IrvingChief Marketing Officer of KPLPMore ExecutivesKey CompetitorsCeres GlobalTSE:CRPAlkaline WaterCVE:WTERSwiss Water Decaffeinated CoffeeTSE:TPKColabor GroupTSE:GCLElse NutritionCVE:BABYView All CompetitorsInsidersMichael KeaysBought 150 shares on 3/14/2024Total: C$1,338.00 ($8.92/share)Dino Joe BiancoBought 1,500 shares on 12/15/2023Total: C$13,620.00 ($9.08/share)Michael KeaysBought 100 shares on 11/20/2023Total: C$972.00 ($9.72/share)View All Insider Transactions KPT Stock Analysis - Frequently Asked Questions Should I buy or sell KP Tissue stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for KP Tissue in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" KPT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KPT, but not buy additional shares or sell existing shares. View KPT analyst ratings or view top-rated stocks. What is KP Tissue's stock price target for 2024? 3 equities research analysts have issued 12 month target prices for KP Tissue's stock. Their KPT share price targets range from C$9.00 to C$12.00. On average, they predict the company's stock price to reach C$9.88 in the next year. This suggests a possible upside of 9.4% from the stock's current price. View analysts price targets for KPT or view top-rated stocks among Wall Street analysts. How have KPT shares performed in 2024? KP Tissue's stock was trading at C$9.02 at the beginning of 2024. Since then, KPT stock has increased by 0.1% and is now trading at C$9.03. View the best growth stocks for 2024 here. When is KP Tissue's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our KPT earnings forecast. How often does KP Tissue pay dividends? What is the dividend yield for KP Tissue? KP Tissue announced a quarterly dividend on Thursday, March 7th. Investors of record on Monday, April 1st will be paid a dividend of 0.18 per share on Monday, April 15th. This represents a $0.72 dividend on an annualized basis and a yield of 7.97%. The ex-dividend date is Thursday, March 28th. Read our dividend analysis for KPT. Is KP Tissue a good dividend stock? KP Tissue (TSE:KPT) pays an annual dividend of C$0.72 per share and currently has a dividend yield of 8.38%. KPT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for KPT. What other stocks do shareholders of KP Tissue own? Based on aggregate information from My MarketBeat watchlists, some companies that other KP Tissue investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Open Text (OTEX), Rogers Communications (RCI) and Valeant Pharmaceuticals International (VRX). How do I buy shares of KP Tissue? Shares of KPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:KPT) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KP Tissue Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.